Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triptorelin 4-Month SR in Prostate Cancer
NCT00415246Phase 3Terminated
- Sponsor
- Ipsen
- Start
- Nov 2006
- Modality
- Peptides, Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of triptorelin in prostate cancer (PCa), sponsored by Ipsen. Started Nov 2006; status: terminated.
02
Drugs
triptorelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00415246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00415246.